Abstract
Objective
The present study aims to compare the clinical and reproductive outcomes of women who have undergone lymph node dissection with those who have not and to discuss the indications for retroperitoneal evaluation in the treatment of borderline ovarian tumors.
Methods
The present study investigated 123 women who were finally diagnosed with borderline epithelial ovarian tumors at the study center between January 1999 and January 2009. A total of 68 patients (55.3%) were found to have a complete surgical staging procedure.
Results
The patients who underwent complete lymph node dissection were significantly younger than those who did not have lymphadenectomy. Thus, the ratio of postmenopausal women was significantly higher among those in whom retroperitoneal evaluation was performed. As expected, the intraoperative blood loss was significantly more and the hospital stay was significantly longer in patients who underwent complete lymph node dissection. Also, the non-serous borderline ovarian tumors were significantly more frequent in the latter patient group. However, overall and disease-free survival spans were found to be statistically similar for both study groups as well as the recurrence rate.
Conclusions
Retroperitoneal evaluation can be spared in every woman with borderline ovarian tumor unless she is to undergo complete surgical staging procedure because of high recurrence risk, advanced stage disease or personal choice.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Menzin AW (2001) Borderline ovarian tumors. Prim Care Update Ob Gyns 8:149–152
Seidman JD, Ronnett BM, Kurman RJ (2002) Pathology of (low malignant potential) ovarian tumors. Best Pract Res Clin Obstet Gynaecol 16(4):499–512
Ohta T, Ohmichi M, Hayasako T, Snitoh M, Kojimahara T, Kawagee J, Nakahara K, Motoyama T, Kurachi H (2005) Characteristic features of ovarian borderline tumors with invasive implant. Arch Gynecol Obstet 272(4):278–282
Silverberg SG, Bell DA, Kurman RJ et al (2004) Borderline ovarian tumors: key points and workshop summary. Hum Pathol 35(8):910–917
Gershenson DM (2002) Clinical management of potential tumors of low malignancy. Best Pract Res Clin Obstet Gynaecol 16(4):513–527
Jaffe E, Harris N, Stein H, Vardiman J (2003) WHO classification of tumours-pathology and genetics of tumours of the breast and female genital organs. IARC Press, Lyon
Sherman ME, Mink PJ, Curtis R et al (2004) Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis. Cancer 100(5):1045–1052
Yavuzcan A, Baloglu A, Cetinkaya B (2009) The investigation of the factors affecting retroperitoneal lymph node metastasis in stage IIIC and IV epithelial ovarian cancer. Arch Gynecol Obstet 280(6):939–944
Rao GG, Skinner E, Gehrig PA, Duska LR, Coleman RL, Schorge JO (2004) Surgical staging of ovarian low malignant potential tumors. Obstet Gynecol 104(2):261–266
Pirimoglu ZM, Afsin Y, Guzelmeric K, Yilmaz M, Unal O, Turan MC (2008) Is it necessary to do retroperitoneal evaluation in borderline ovarian tumors? Arch Gynecol Obstet 277:411–414
Yoshinaka A, Fukusawa I, Sakamoto T, Tanaka M, Ota Y, Inabe N (2000) The fertility and pregnancy outcomes of the patients who underwent preservative operation followed by adjuvant chemotherapy for malignant ovarian tumors. Arch Gynecol Obstet 264(3):124–127
Chan JK, Lin YG, Loizzi V, Ghobriel M, DiSaia PJ, Berman ML (2003) Borderline ovarian tumors in reproductive-age women. Fertility-sparing surgery and outcome. J Reprod Med 48:756–760
Jones MB (2006) Borderline ovarian tumors: current concepts for prognostic factors and clinical management. Clin Obstet Gynecol 49:517–525
Boriboonhirusam D, Sermboon A (2004) Accuracy of frozen section in the diagnosis of malignant ovarian tumor. J Obstet Gyneacol Res 30:394–398
Boran N, Cil AP, Tulunay G (2005) Fertility and recurrence results of conservative surgery for borderline ovarian tumors. Gynecol Oncol 97:845
Trimble CL, Trimble EL (2003) Ovarian tumors of low malignant potential. Oncology (Huntingt) 17:1563
Morice P, Camette S, El Hassan J (2001) Clinical outcomes and fertility after conservative treatment of ovarian borderline tumors. Fertil Steril 75:92
Suh-Burgmann E (2006) Long-term outcomes following conservative surgery for borderline tumor of the ovary: a large population-based study. Gynecol Oncol 103:841
Zanetta G, Rota S, Chiari S (2001) Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study. J Clin Oncol 19:2658
Morice P, Camatte S, Rey A (2003) Prognostic factors for patients with advanced stage serous borderline tumours of the ovary. Ann Oncol 14:592
Gershenson DM (2002) Is micropapillary serous carcinoma for real? Cancer 95:677
Buttin BM, Herzog TJ, Powell MA, Rader JS (2002) Epithelial ovarian tumors of low malignant potential: the role of microinvasion. Obstet Gynecol 99:11
Sood AK, Abu-Rustum NR, Barakat RR (2005) Fifth international conference on ovarian cancer: challenges and opportunities. Gynecol Oncol 97:916
Geomini P, Bremer G, Kruitwagen R, Mol BW (2005) Diagnostic accuracy of frozen section diagnosis of the adnexal mass: a meta-analysis. Gynecol Oncol 96:1
Conflict of interest statement
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kanat-Pektas, M., Ozat, M., Gungor, T. et al. Complete lymph node dissection: is it essential for the treatment of borderline epithelial ovarian tumors?. Arch Gynecol Obstet 283, 879–884 (2011). https://doi.org/10.1007/s00404-010-1539-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-010-1539-5